Bendle G - Search Results

1

Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers.

Scheper W, Kelderman S, Fanchi LF, Linnemann C, Bendle G, de Rooij MAJ, Hirt C, Mezzadra R, Slagter M, Dijkstra K, Kluin RJC, Snaebjornsson P, Milne K, Nelson BH, Zijlmans H, Kenter G, Voest EE, Haanen JBAG, Schumacher TN. Scheper W, et al. Among authors: bendle g. Nat Med. 2019 Jan;25(1):89-94. doi: 10.1038/s41591-018-0266-5. Epub 2018 Dec 3. Nat Med. 2019. PMID: 30510250

2

TCR gene therapy of spontaneous prostate carcinoma requires in vivo T cell activation.

de Witte MA, Bendle GM, van den Boom MD, Coccoris M, Schell TD, Tevethia SS, van Tinteren H, Mesman EM, Song JY, Schumacher TN. de Witte MA, et al. J Immunol. 2008 Aug 15;181(4):2563-71. doi: 10.4049/jimmunol.181.4.2563. J Immunol. 2008. PMID: 18684947 Free PMC article.

3

Requirements for effective antitumor responses of TCR transduced T cells.

de Witte MA, Jorritsma A, Kaiser A, van den Boom MD, Dokter M, Bendle GM, Haanen JB, Schumacher TN. de Witte MA, et al. Among authors: bendle gm. J Immunol. 2008 Oct 1;181(7):5128-36. doi: 10.4049/jimmunol.181.7.5128. J Immunol. 2008. PMID: 18802117

4

Preclinical development of T cell receptor gene therapy.

Bendle GM, Haanen JB, Schumacher TN. Bendle GM, et al. Curr Opin Immunol. 2009 Apr;21(2):209-14. doi: 10.1016/j.coi.2009.02.007. Epub 2009 Mar 25. Curr Opin Immunol. 2009. PMID: 19321326 Review.

5

Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis.

Wright GP, Notley CA, Xue SA, Bendle GM, Holler A, Schumacher TN, Ehrenstein MR, Stauss HJ. Wright GP, et al. Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):19078-83. doi: 10.1073/pnas.0907396106. Epub 2009 Nov 2. Proc Natl Acad Sci U S A. 2009. PMID: 19884493 Free PMC article.

6

Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy.

Bendle GM, Linnemann C, Hooijkaas AI, Bies L, de Witte MA, Jorritsma A, Kaiser AD, Pouw N, Debets R, Kieback E, Uckert W, Song JY, Haanen JB, Schumacher TN. Bendle GM, et al. Nat Med. 2010 May;16(5):565-70, 1p following 570. doi: 10.1038/nm.2128. Epub 2010 Apr 18. Nat Med. 2010. PMID: 20400962

7

T-cell receptor gene therapy: critical parameters for clinical success.

Linnemann C, Schumacher TN, Bendle GM. Linnemann C, et al. Among authors: bendle gm. J Invest Dermatol. 2011 Sep;131(9):1806-16. doi: 10.1038/jid.2011.160. Epub 2011 Jun 16. J Invest Dermatol. 2011. PMID: 21677669 Free article. Review.

8

Blockade of TGF-β signaling greatly enhances the efficacy of TCR gene therapy of cancer.

Bendle GM, Linnemann C, Bies L, Song JY, Schumacher TN. Bendle GM, et al. J Immunol. 2013 Sep 15;191(6):3232-9. doi: 10.4049/jimmunol.1301270. Epub 2013 Aug 12. J Immunol. 2013. PMID: 23940272

9

High-throughput identification of antigen-specific TCRs by TCR gene capture.

Linnemann C, Heemskerk B, Kvistborg P, Kluin RJ, Bolotin DA, Chen X, Bresser K, Nieuwland M, Schotte R, Michels S, Gomez-Eerland R, Jahn L, Hombrink P, Legrand N, Shu CJ, Mamedov IZ, Velds A, Blank CU, Haanen JB, Turchaninova MA, Kerkhoven RM, Spits H, Hadrup SR, Heemskerk MH, Blankenstein T, Chudakov DM, Bendle GM, Schumacher TN. Linnemann C, et al. Among authors: bendle gm. Nat Med. 2013 Nov;19(11):1534-41. doi: 10.1038/nm.3359. Epub 2013 Oct 13. Nat Med. 2013. PMID: 24121928

10

RNAi-mediated TCR knockdown prevents autoimmunity in mice caused by mixed TCR dimers following TCR gene transfer.

Bunse M, Bendle GM, Linnemann C, Bies L, Schulz S, Schumacher TN, Uckert W. Bunse M, et al. Among authors: bendle gm. Mol Ther. 2014 Nov;22(11):1983-91. doi: 10.1038/mt.2014.142. Epub 2014 Jul 22. Mol Ther. 2014. PMID: 25048215 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page